It's pretty important to be aware of these possible effects
Researchers found that people taking weekly semaglutide injections reduced how much they drank, reported lowered alcohol cravings, and noted fewer heavy drinking days compared to placebo
This is worth knowing as a clinician because a patient adjusting to a new or increased dose of a GLP-1 may experience reduced appetite and energy, which could affect their participation in therapy
5a-hydroxy Laxogenin, recognized for its anabolic properties, explores muscle-related outcomes, while PEA with Levagen delves into anti-inflammatory and analgesic potentials
It's just, I think it might be useful to you that physician is protected or not protected if something negative happens to the patient
Aleksandra Gajer on the podcast today